Search research articles
Contact Us
Filters
Showing results (61-70 of 127) with videos related to
Page
of 13
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
July 27, 2020
Maja Ann Hofmann, Ulrike Keim, Agata Jagoda, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 6, 2013
Brief S2k guidelines--Cutaneous squamous cell carcinoma
Helmut Breuninger, Thomas Eigentler, Friedrich Bootz, et al.
Cancers
|
June 24, 2022
Combination of Whole-Body Baseline CT Radiomics and Clinical Parameters to Predict Response and Survival in a Stage-IV Melanoma Cohort Undergoing Immunotherapy
Felix Peisen, Annika Hänsch, Alessa Hering, et al.
The Journal of Investigative Dermatology
|
September 30, 2011
CHEK2*1100delC and risk of malignant melanoma: Danish and German studies and meta-analysis
Maren Weischer, Ida M Heerfordt, Stig E Bojesen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 19, 2019
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma
Sophia Kreft, Anja Gesierich, Thomas Eigentler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 3, 2009
Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial
Sarah Heinze, Friederike Egberts, Susanne Rötzer, et al.
Immunotherapy
|
January 5, 2019
Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis
Teresa Amaral, Ioanna Tampouri, Thomas Eigentler, et al.
Journal of Cancer Research and Clinical Oncology
|
February 22, 2022
TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy
Julia Eckardt, Christopher Schroeder, Peter Martus, et al.
International Journal of Environmental Research and Public Health
|
July 27, 2022
eHealth Literacy in German Skin Cancer Patients
Henner Stege, Sara Schneider, Andrea Forschner, et al.
Plos One
|
August 17, 2019
Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade
Jonas Bochem, Henning Zelba, Teresa Amaral, et al.
Page
of 13
Search research articles
Search
Showing results (61-70 of 127) with videos related to
Sort By:
Page
of 13
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
July 27, 2020
Maja Ann Hofmann, Ulrike Keim, Agata Jagoda, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
June 6, 2013
Brief S2k guidelines--Cutaneous squamous cell carcinoma
Helmut Breuninger, Thomas Eigentler, Friedrich Bootz, et al.
Cancers
|
June 24, 2022
Combination of Whole-Body Baseline CT Radiomics and Clinical Parameters to Predict Response and Survival in a Stage-IV Melanoma Cohort Undergoing Immunotherapy
Felix Peisen, Annika Hänsch, Alessa Hering, et al.
The Journal of Investigative Dermatology
|
September 30, 2011
CHEK2*1100delC and risk of malignant melanoma: Danish and German studies and meta-analysis
Maren Weischer, Ida M Heerfordt, Stig E Bojesen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 19, 2019
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma
Sophia Kreft, Anja Gesierich, Thomas Eigentler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 3, 2009
Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial
Sarah Heinze, Friederike Egberts, Susanne Rötzer, et al.
Immunotherapy
|
January 5, 2019
Immunotherapy plus surgery/radiosurgery is associated with favorable survival in patients with melanoma brain metastasis
Teresa Amaral, Ioanna Tampouri, Thomas Eigentler, et al.
Journal of Cancer Research and Clinical Oncology
|
February 22, 2022
TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy
Julia Eckardt, Christopher Schroeder, Peter Martus, et al.
International Journal of Environmental Research and Public Health
|
July 27, 2022
eHealth Literacy in German Skin Cancer Patients
Henner Stege, Sara Schneider, Andrea Forschner, et al.
Plos One
|
August 17, 2019
Peripheral PD-1+CD56+ T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade
Jonas Bochem, Henning Zelba, Teresa Amaral, et al.
Page
of 13